Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
2013
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals
2022 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage
2008
European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators
2010 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Intracerebral haemorrhage
2009 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Paediatric pharmacogenomics: an overview
2012
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor
2012
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
Oral Anticoagulant Therapy
2012 Standout
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Emergency Neurological Life Support: Intracerebral Hemorrhage
2012
Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence‐based approaches
2010
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
2009
Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects
2011
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Detection of a novel DNA virus (TT virus) in blood donors and blood products
1998
Liver biopsy†
2008
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
2015
Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate
2008
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Non-viral vectors for gene-based therapy
2014 Standout
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
2011
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
The Missing Diversity in Human Genetic Studies
2019 Standout
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Immune tolerance induction in haemophilia: evidence and the way forward
2011
Recognition of Conserved Amino Acid Motifs of Common Viruses and Its Role in Autoimmunity
2005 StandoutNobel
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support
2010 Standout
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Prevalence, Incidence, and Clinical Characteristics of Hepatitis G Virus/GB Virus C Infection in Scottish Blood Donors
1998
IgG Subclass Distribution of Hepatitis B Surface Antigen Antibodies Induced in Children with Chronic Hepatitis B Infection after Interferon‐α Therapy
2000
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
2011
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Hepatitis C virus and interferon resistance
2000
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Reversal of Elevated International Normalized Ratios and Bleeding with Low‐Dose Recombinant Activated Factor VII in Patients Receiving Warfarin
2006
High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy
1999 StandoutNobel
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature
2007
European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution
2010
Toll‐like receptor 4 contributes to poor outcome after intracerebral hemorrhage
2011 StandoutNobel
Massive transfusion and nonsurgical hemostatic agents
2008
What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?
2008
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data
2008
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage
2015
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis
2017
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study
1997
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Foot-and-Mouth Disease
2004 Standout
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy
2005
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update
2017
Prothrombin Complex Concentrate Accelerates International Normalized Ratio Reversal and Diminishes the Extension of Intracranial Hemorrhage in Geriatric Trauma Patients
2014
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
2017
Study of physical function in adolescents with haemophilia: The SO‐FIT study
2017
Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF.
1999
Type I interferon production in cattle infected with 2 strains of foot-and-mouth disease virus, as determined by in situ hybridization.
2000
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
Identification of Rodent Homologs of Hepatitis C Virus and Pegiviruses
2013 StandoutNobel
The increasing incidence of anticoagulant-associated intracerebral hemorrhage
2007
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Identification of a Pegivirus (GB Virus-Like Virus) That Infects Horses
2013 StandoutNobel
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
2008
Dabigatran bleed risk with closed head injuries: are we prepared?
2013
Hematoma Growth and Outcome in Treated Neurocritical Care Patients With Intracerebral Hemorrhage Related to Oral Anticoagulant Therapy
2006
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV‐C/HGV) RNA and those with GBV‐C/HGV E2‐antibody in patients with hemophilia
1999
Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis
2020
Mir‐142‐3p target sequences reduce transgene‐directed immunogenicity following intramuscular adeno‐associated virus 1 vector‐mediated gene delivery
2013
AASLD position paper: Liver biopsy
2008
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Guidelines for the management of hemophilia
2012 Standout
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout
Works of John Hanley being referenced
Development of anti‐interferon antibodies and breakthrough hepatitis during treatment for HCV infection in haemophiliacs
1996
Warfarin reversal
2004
Recombinant activated factor VII (rFVIIa/NovoSeven®) in intractable haemorrhage: use of a clinical scoring system to predict outcome
2005
A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia A
2010
The Biology of Interferon-α and the Clinical Significance of Anti-Interferon Antibodies
1998
Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non‐invasive methods
1996
Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
2009
Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population
2015
VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children
2011
Interferon treatment for chronic HCV infection in haemophiliacs
1995
Patterns of Hepatitis G Viraemia and Liver Disease in Haemophiliacs Previously Exposed to Non-virus Inactivated Coagulation Factor Concentrates
1998
UKHCDO Acquired Haemophilia Study: A Complete National Cohort.
2005
Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use
2009